Introduction 1
The viability of growing cells demands that membrane synthesis be tightly orchestrated 2 with biomass production. The mechanisms that adjust synthesis rates of membrane components 3 (e.g. phospholipids and lipopolysaccharides) during steady-state growth or in response to 4 environmental perturbations remain unknown (1). Recently, advances in analytical methods and 5 systems-level modelling have delivered new insights into how living cells control enzyme 6 reaction rates. Reaction rates (metabolic fluxes) may be modulated through either changes in 7 enzyme concentrations mediated by transcriptional regulation, or by adjusting the activities of 8 enzymes that are already present by post-translational regulation. Two groups inferred 9 mechanisms of flux control by quantifying metabolic fluxes and concentrations of metabolites 10 and enzymes during steady-state growth in various conditions (2, 3). Both groups concluded that 11 pathway fluxes are more often determined by steady-state concentrations of substrates and 12 inhibitors than by concentrations of enzymes. In other words, steady-state flux is controlled in 13 many pathways by post-translational regulation of enzyme activity rather than by transcriptional 14 regulation of enzyme abundance. On the other hand, the global synthesis rate of proteins -the 15 most abundant form of biomass -is determined in many fast-growing bacteria by ribosome 16 abundance, which is transcriptionally regulated to balance amino acid supply with consumption 17 (4) . Whether membrane synthesis flux is regulated either via transcriptional control (similar to 18 protein synthesis) or by post-translational control remains unknown. 19
The architecture and composition of the cell envelope in Gram-negative bacteria also 20 demands tight coordination between multiple biosynthesis pathways. The inner membrane and 21 the inner leaflet of the outer membrane are composed primarily of phospholipids (PL), while the 22 outer leaflet of the outer membrane is composed of lipopolysaccharides (LPS) (5, 6). PL and 23 LPS pathways must also be coordinated with protein synthesis, which supplies lipoproteins (e.g. 24
Lpp) that tether the outer membrane to peptidoglycan (7). In Escherichia coli, a model organism 25
Page 7 of 33 and thus PlsB abundance, is controlled by the μ-sensitive regulator guanosine tetraphosphate 1 (ppGpp) (21) and by the membrane stress-activated sigma factor RpoE (22). Concentrations of 2 ppGpp are inversely correlated with μ ( Figure 1D) , implying that PL flux may be coupled to μ by 3 transcriptional control of the plsB gene by ppGpp. We measured fatty acid and PL synthesis 4 pathway enzymes in each culture using LC/MS to determine whether enzyme concentrations are 5 adjusted to couple PL flux with μ. We found no significant correlation between PL synthesis flux 6 and PlsB concentration (Figure 1G (Figure 2C) . We therefore conclude that PL synthesis 6 flux is primarily regulated during steady-state growth by allosteric control of PlsB activity. 7
However, changes in acetyl-CoA concentration or ACC activity may also influence PL flux during 8 environmental or metabolic perturbations. 9
ppGpp attenuates excess lipid synthesis triggered by translation inhibition 10
We set out to evaluate whether a known allosteric regulator of PlsB, ppGpp, is able to 11 directly regulate PlsB activity during steady-state growth. High concentrations of ppGpp are 12 known to inhibit PlsB (24), while low concentrations of ppGpp correlate inversely with μ ( Figure  13 1D). The notion that ppGpp concentrations might regulate PL synthesis even at the low basal 14 concentrations present during steady-state growth has been proposed but never tested (26) . 15
Although steady-state PlsB activity clearly decreased in response to ppGpp titration, the mode of 16 control by ppGpp (transcriptional regulation of a PlsB-regulating process or protein, or direct 17 post-translational inhibition) cannot be determined from steady-state data. However, we first 18 wished to observe the effects of high concentrations of ppGpp on fatty acid and PL synthesis 19 using our assay. Synthesis of high concentrations of ppGpp by RelA (the stringent response) is 20 triggered by any stress or starvation conditions that lead to the specific biochemical cue of 21 uncharged tRNA bound to the ribosome. During the stringent response, ppGpp accumulates by 22 more than 10-fold over basal concentrations and PL synthesis rates are reduced by 23 approximately half (24, 26), likely due to PlsB inhibition (27). 24
Page 10 of 33
We triggered ppGpp accumulation by adding the tRNA aminoacylation inhibitor mupirocin 1 to glucose cultures of wild-type and ∆relA E. coli. Mupirocin inhibits translation in both strains 2 and causes a 10-fold accumulation of ppGpp in the wild-type strain within 1 minute to over 400 3 pmol/OD, reaching >800 pmol/OD after 3 minutes (Supplemental Figures 4, 5) . To our 4 surprise, mupirocin treatment also transiently increased malonyl-ACP and hydroxyl-ACP at the 5 expense of holo-ACP in both strains ( Figure 3A, Supplemental Figure 6 ). The increase in acyl-6 ACP is matched by a corresponding increase in PL synthesis intermediates, suggesting that 7 mupirocin diverts a pulse of carbon into the fatty acid pathway that is efficiently transmitted into 8 PL synthesis ( Figure 3B ). In the wild-type strain, the pulse of fatty acid synthesis activity is 9 rapidly followed by C16:0-and C18:0-ACP accumulation, consistent with ppGpp inhibition of 10 acid elongation also depletes LPS precursor C14:0-OH-ACP, which is expected to decrease 20 LPS synthesis in parallel with PL synthesis ( Figure 3A) . 21
As the transient increase in fatty acid synthesis after mupirocin treatment occurs in both 22 wild-type and ∆relA strains, we hypothesized that it is caused by translation inhibition. We added 23 the ribosome inhibitor chloramphenicol and the transcription initiation inhibitor rifampicin to 24 glycerol cultures of wild-type E. coli. Both compounds inhibit translation via mechanisms that Page 11 of 33 suppress ppGpp synthesis. As with mupirocin, chloramphenicol triggered a rapid decrease in 1 holo-ACP and an increase in long-chain unsaturated acyl-ACP species C16:1-ACP and C18:1-2 ACP ( Figure 3C ). Both antibiotics triggered an increase in PL synthesis intermediates PA and 3 PS that resembled the increase observed in the ∆relA strain after mupirocin treatment ( Figure  4 3D). 5
What might cause the transient increase in fatty acid synthesis observed after translation 6 inhibition? Interestingly, both rifampicin and chloramphenicol increased acetyl-CoA 7 concentrations by 3-fold ( Figure 3E ), suggesting a possible cause. Acetyl-CoA also increased in 8 both the wild-type and the ∆relA strain after mupirocin addition in glucose medium before 9 decreasing ~30% in the wild-type strain (Supplemental Figures 4, 5) . While it is unclear why 10 translation inhibition would increase acetyl-CoA, the effects of acetyl-CoA variation on fatty acid 11 and PL synthesis suggests that both pathways are highly sensitive to its concentration, a finding 12 that agrees with the sensitivity predicted by our mathematical model. We confirmed the 13 sensitivity of the fatty acid and PL synthesis pathways to environmental changes using a fast 14 nutritional upshift. Addition of glucose and amino acids to a glycerol culture also caused a rapid 15 accumulation of PA and PS species that resemble the increases observed following translation 16 inhibition (Supplemental Figure 8) . 17
Moderate ppGpp concentrations regulate PlsB via post-translational control 18
In order to clearly discern the effects of ppGpp on the fatty acid and PL synthesis 19 pathways without complications introduced by translation inhibition, we monitored fatty acid and 20 PL synthesis pathways after inducing RelA*. The response in the fatty acid and PL synthesis 21 pathways is consistent with PlsB inhibition by ppGpp followed by ACC activity suppression by 22 accumulated long-chain acyl-ACP, depleting malonyl-ACP ( Figure 4A ). PL intermediates also 23 respond in a manner consistent with PlsB inhibition: LPA species steadily decrease, followed by 24 PA, PS, and PG ( Figure 4B ). Addition of chloramphenicol 10 minutes following RelA* induction Page 12 of 33 causes an increase in unsaturated long-chain acyl-ACP, though the response of the PL pathway 1 is attenuated. We note that the PS pool is depleted more after ppGpp induction than are the LPA 2 or PA pools, suggesting an additional regulatory mechanism downstream of PlsB. 3
We next sought to evaluate whether basal ppGpp concentrations are also capable of 4 regulating PlsB via post-translational control. As the effects of post-translational control are more 5 rapidly apparent than those that follow transcriptional regulation, we followed the timescale of 6 the response of the PL pathway to ppGpp synthesis. We measured ppGpp and PL synthesis 7 intermediates during RelA* induction to moderate levels. ppGpp increased within 10 minutes of 8
RelA* induction and reached its elevated steady-state concentration (~150 pmol/OD) by 20 9 minutes. Concentrations of PL intermediates PA and PS began to decrease within 10 minutes 10 ( Figure 4C ). Interestingly, PS decreases further after ~25 minutes, at which point PA increases 11
slightly, suggesting that PS may be back-converted to PA by PssA (28) ( Figure 4C) by ppGpp) to re-balance the pathway with μ and prevent PL overflow. If protein synthesis is 8 inhibited in a manner that does not decrease carbon flow into the fatty acid pathway (e.g. by 9
sudden nitrogen starvation), we hypothesize that continued PL and LPS synthesis would 10 outpace synthesis of the lipoproteins that tether the outer membrane to the peptidoglycan layer. 11
Inhibition of PL and LPS pathways by ppGpp would thus prevent production of excess 12 membrane, enforcing the coupling of PL and lipoprotein synthesis. Strains lacking the ppGpp 13 response (relaxed strains) have been observed to generate higher quantities of extracellular PL 14 and LPS, likely as outer membrane vesicles (35) . 15 We estimate that post-translational control of PlsB by ppGpp, reflected by a relatively 16 high effective K I (~300 pmol/OD), indicates that ppGpp regulates PL synthesis as an emergency 17 brake, and is unlikely to couple PL synthesis to growth in conditions that support μ > 0.5 hr -1 . 18
Although it is generally believed that ppGpp directly inhibits PlsB, multiple groups have been 19 unable to observe ppGpp inhibition of PlsB in vitro when acyl-ACP are used as substrates (36, 20 37). ppGpp may therefore control PlsB indirectly by modulating activity of a regulator or a cellular 21 process that interacts with PlsB. 22
Several candidates for the allosteric regulator of PlsB activity have been discovered. In 23 immunoprecipitation experiments, PlsB has been found to interact with proteins including ACP 24
and PssA, as well as several whose roles are unclear (PlsX and YbgC) (38), suggesting that 25 Page 16 of 33 PlsB forms part of a PL synthesis complex that may couple PlsB activity with μ. As PL synthesis 1 flux has been observed to oscillate with the cell division cycle in E. coli and other bacteria (39), 2
PlsB may also be regulated by the divisome, membrane deformation, or by associations with the 3 Tol-Pal machinery. Degradation of PL by phospholipases may also play an important role in 4 membrane homeostasis during steady-state growth (40), as is known to occur during growth and 5 division in eukaryotes (41). In addition to identifying the allosteric regulators of PlsB, studies that 6 integrate connections between PL catabolism and transport with PL synthesis are needed for a 7 comprehensive understanding of membrane homeostasis. At OD of ~0.5 10% TCA was added 1:4 to the culture to facilitate quenching of metabolism. After 7 10 min incubation on ice 10 mL single-use IS aliquots were collected by centrifugation and 8 stored at -80°C until the sample preparation. For the phospholipid measurement U-13 C lipid 9 extract was prepared using a culture grown in minimal MOPS medium with 0.2% U-13 C glucose 10 as the sole carbon source. At OD of ~0.5 10% TCA was added 1:4 to the culture and insoluble 11 cell material was collected by centrifugation after 10 min incubation on ice. Pellets were 12 resuspended in mixture consisting of 75 μL MeOH, 10 μL 15 mM citric acid/ 20 mM dipotassium 13 phosphate buffer and 250 μL of methyl-t-butyl ether per 1 mL of initial culture volume. After 14 vortexing and 10 min sonication phase separation was induced by addition of 70 μL/1mL of 15 15 mM citric acid/ 20 mM dipotassium phosphate buffer. After further vortexing, sonication and 10 16 minutes of incubation at room temperature phases were separated by 10 min centrifugation at 17 4000 rpm at room temperature. Upper phase was collected to a glass vial and stored at -20°C 18 until sample preparation. 19
Instrumentation 20
All LC/MS runs were performed using Agilent LCMS consisting of binary pump 21 (G1312B), autosampler (G7167A), temperature-controlled column compartment (G1316A), and 22 triple quadrupole (QQQ) mass spectrometer (G6460C) equipped with a standard ESI source, all 23 operated using MassHunter data acquisition software (version 7.0). Mass spectrometer operated 24
Page 20 of 33 in dynamic MRM mode using transitions generated in silico by a script written in Python using 1 RDkit library using chemical structures of target compound as input. Transitions for targeted 2 proteomics assays were developed using Skyline (45) based on protein sequences from the 3 Uniprot database. Details of transition setting are included in Supplemental Tables 3-7 . 4
LC/MS quantification of acyl-ACP intermediates 5
Acyl-ACP were measured using a published method (18) with minor modifications. Lysis 6 buffer was prepared by suspending appropriate number of frozen U-15 N-labeled E. coli pellets in 7 10 mL of 50 mM potassium phosphate buffer, pH 7.2, 6 M urea, 10 mM N-ethyl-maleimide, 5 8 mM EDTA and 1 mM ascorbic acid. 1 mL of lysis buffer was added to each of TCA-quenched 9
and pelleted cells and proteins were isolated by chloroform/methanol precipitation as described 10 previously. Protein pellets were resuspended in 10 μL of digestion buffer (4% 2-octyl-glucoside 11 in 25 mM potassium phosphate buffer, pH 7.2) and after adding 10 μL of 0.1 mg/mL GluC 12 protease (Promega) incubated overnight at 37°C. After quenching by addition of 5 μL MeOH, 13 samples were centrifuged and 10 μL was injected in LC/MS system. Separation was performed 14 on 2.1 mm x 50 mm 1.7 μm CSH C-18 column (Waters) held at 80°C using a binary gradient: 15 15% B, 3 minute ramp to 25%, 9 min increase to 95% and 1 minute hold at 95% B before 3 16 minute re-equilibration at starting conditions (A: 25 mM formic acid, B: 50 mM formic acid) at a 17 flow rate of 0.6 mL/min. 18
LC/MS quantification of phospholipids 19
Phospholipids sample preparation procedure is a combination of an MTBE extraction 20 method (46) and an established LC/MS method (47) Pelleted E. coli were resuspended in 21 mixture containing 150 μL of MeOH, 250 μL of U-13 C E. coli extract prepared as described 22 above and 250 μL MTBE. After vigorous vortexing and sonication 125 μL of 15 mM citric acid/ 23 20 mM dipotassium phosphate buffer was added to homogenized pellets. Following further 24
Page 21 of 33 vortexing and 10 min incubation at room temperature, liquid phases were separated by 1 centrifugation for 10 min at 20000g. 500 μL the of upper phase was moved to a new tube and 2 dried in a vacuum centrifuge (Labconco). Dried lipid films were resuspended in 10 μL 65:30:5 3
(v/v/v) isopropanol/acetonitrile/H 2 O, supplemented with 10 mM acetylacetone. After 4 resuspension, 5 μL H 2 O was added to reduce the organic content of the buffer and 5 μL of 5 resulting mixture was injected into the LC/MS system. Separation was performed on 2.1 mm x 6 50 mm 1.7 μm CSH C-18 column (Waters) at 60°C with a flow rate of 0.6 mL/min using the 7 following binary gradient: 25% B, ramp to 56%B in 6 min followed by linear increase to 80% B in 8 6 min, 2 min hold at 100% B and 3 min re-equilibration (A: 0.05% NH4OH in water, B: 0.05% 9 NH 4 OH in 80% isopropanol 20% ACN). 10
LC/MS quantification of nucleotide phosphates 11
Frozen cell extracts were defrosted by 1-2 minute incubation in a 37°C water bath and 12 sonicated for 10 minutes in water ice slurry. After 10 minute centrifugation at 20000g, samples 13 analysis. Separation was performed on 2.1 mm x 100 mm 3.5 μm iHilic column (HILICON) at 0.3 6 mL/min using the following binary gradient: 100% B, ramp to 80% B in 10 min followed by linear 7 decrease to 30% B in 3 min, 2 min hold at 30% B and 8 min re-equilibration. Injection volume 8 was 2 μL. 9
LC/MS targeted protein quantification 10
Relative concentrations of enzymes was measured by targeted proteomics using a 11 modified version of the acyl-ACP assay. Lysis buffer was prepared by suspending appropriate 12 number of frozen U-15 N-labeled E. coli pellets in 10 mL of 50 mM potassium phosphate buffer, 13 pH 7.2 and 6 M urea. 1 mL of lysis buffer was added to each of TCA-quenched and pelleted 14 cells and proteins were isolated by chloroform/methanol precipitation as described previously. 15
Protein pellets were resuspended in 10 μL of digestion buffer (4% 2-octyl-glucoside in 25 mM 16
Tris buffer, pH 8.1 supplemented with 1 mM CaCl 2 and 5 mM TCEP). Alkylation of cysteine 17 residues was performed by adding 3 μL of 50 mM iodoacetamide followed by 15 minutes of 18 incubation in darkness. Digestion was performed by adding 10 μL of 0.2 mg/mL Trypsin Gold 19 (Promega) and overnight incubation at 37°C. Samples were centrifuged and 10 μL was injected 20 in LCMS system. Separation was performed on 2.1 mm x 50 mm 1.7 μm CSH C-18 column 21 (Waters) held at 40°C using a binary gradient: 2% B, 20 minute ramp to 25% B, 4 min increase 22 to 40% B, 0.5 ramp to 80% and 1 minute hold at 80% B before 3 minute re-equilibration at 23 starting conditions (A: 25 mL formic acid, B: 50 mM formic acid) at a flow rate of 0.5 mL/min.
Data Analysis 1
All LC-MS data files were processed in Skyline versions 4.x using target list based on in 2 silico generated transition list. Each target compound had matching isotopically-labeled internal 3 standard (IS). Processed data were exported as target compounds and IS peak areas and 4 processed further using a set of Python scripts. Growth rates were obtained from linear fits to 5 log-transformed growth curves. OD-corrected data were obtained by dividing the signal by OD 600 6 value interpolated from growth curve at the time of sampling. PE-corrected results were 7 produced by dividing the signal by sum all of signals for all phosphatidyl-ethanolamine species 8 from the same measurement (in case of phospholipids) or matching sample (in case of other 9 assays). In nucleotide phosphate and G3P assay absolute concentrations were estimated based 10 on amounts of internal standards in IS-spike solution assuming RR = 1 implies equimolar 11 amounts of target compound and IS at the moment of quenching. Concentrations of IS in the 12 spike mix are provided in the supplement. 13
Mathematical modeling 14
The computational model was constructed and tested using COPASI version 4.24 (48). 15
Full details of the model are described in the Supplemental Methods. 
